Clinical Trials Browser

Terminated × Interventional × STA 9090 × Clear all

NCT01962948 2024-03-26

Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 1/2 Terminated

12 enrolled 8 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT02012192 2019-08-13

GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer

Phase 1/2 Terminated

133 enrolled 10 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Disorders of Sex Development

NCT02261805 2018-04-23

A Phase I/II Study of Ganetespib in Combination With Doxorubicin

Phase 1/2 Terminated

11 enrolled 7 charts

Neoplasms, Small Cell Lung Carcinoma

NCT02192541 2018-03-29

Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas

Phase 1 Terminated

5 enrolled 15 charts

Neoplasms, Sarcoma

NCT01551693 2017-04-12

STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma

Phase 2 Terminated

3 enrolled 7 charts

Melanoma, Neoplasm Metastasis

NCT02334319 2016-07-26

Ganetespib Window of Opportunity Study in Head and Neck Cancers

Phase 1 Terminated

Squamous Cell Carcinoma of Head and Neck

NCT01798485 2016-07-01

Galaxy 2

Phase 3 Terminated

696 enrolled 28 charts

Carcinoma, Non-Small-Cell Lung

NCT01227018 2014-07-23

PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer

Phase 2 Terminated

15 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms